CLDI

Calidi Biotherapeutics, Inc. CLDI

CLDI
Calidi Biotherapeutics, Inc. CMND
Clearmind Medicine Inc. CANF
Can-Fite BioPharma Ltd. KZIA
Kazia Therapeutics Limited TTNP
Titan Pharmaceuticals, Inc. SILO
Silo Pharma, Inc. CNSP
CNS Pharmaceuticals, Inc. SXTP
60 Degrees Pharmaceuticals, Inc. XBIO
Xenetic Biosciences, Inc. QLGN
Qualigen Therapeutics, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode CLDI CMND CANF KZIA TTNP SILO CNSP SXTP XBIO QLGN
6M -58.65 % -93.73 % -82.99 % 30.93 % -46.82 % -37.63 % -31.87 % -70.68 % -29.68 % -14.17 %
YTD -90.89 % -96.11 % -89.93 % -8.57 % -26.65 % -59.44 % -91.17 % -89.48 % -45.31 % -23.57 %
1Y -92.59 % -96.72 % -87.39 % -45.02 % -32.56 % -59.81 % -90.52 % -89.56 % -46.63 % -17.69 %
3Y -99.89 % -99.95 % -97.00 % -68.38 % -85.19 % -86.85 % -99.99 % -99.75 % -23.62 % -95.06 %
5Y -99.89 % -99.97 % -99.03 % -98.23 % -96.41 % 10.09 % -100.00 % -99.75 % -89.89 % -99.81 %
10Y -99.89 % -99.97 % -99.96 % -98.22 % -99.99 % 10.09 % -100.00 % -99.75 % -99.64 % -100.00 %
From the beginning -99.89 % -99.97 % -99.98 % -99.70 % -100.00 % 10.09 % -100.00 % -99.75 % -99.64 % -100.00 %

Dividend